
|Articles|January 1, 2004
AMO, Alcon in dispute over phaco patents
Santa Ana, CA-Advanced Medical Optics (AMO) is claiming, in a complaint filed in federal court, that Alcon's Infiniti and Series 20000 Legacy phacoemulsification systems infringe AMO patents for advanced fluidics technologies in the removal of cataracts.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: nAMD imaging biomarkers and real-world switch outcomes
2
EURETINA 2026: OCT biomarkers that predict, preempt and pinpoint retinal disease
3
EURETINA 2026: Women’s health and pregnancy in the spotlight
4
EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics
5














